Korro Bio, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +125.1% | +401.1% | +18.6% | -30.0% | -60.2% | +200.6% | +2.1% | -49.8% | |
| – | +139.1% | +415.5% | +1.7% | -40.1% | -57.6% | +202.6% | -23.9% | -37.4% | |
| – | +135.2% | +374.4% | +10.1% | -63.9% | -53.6% | +349.8% | -66.5% | -60.8% | |
| – | +135.2% | +415.2% | +1.4% | -40.7% | -57.3% | +197.5% | -24.1% | -40.4% | |
| – | – | +400.0% | -57.8% | -57.6% | +211.8% | -100.0% | – | -42.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | +80.2% | -37.3% | +29.3% | -24.5% | +216.8% | -70.0% | +27.2% | -5.7% | |
| – | +69.6% | +1,298.9% | -49.5% | -57.1% | -23.9% | +123.9% | -23.2% | -20.2% | |
| – | – | – | +39,699,900.0% | +549.9% | +13.2% | -31.8% | -35.5% | +108.1% | |
| – | +87.4% | -34.6% | +351.7% | -50.1% | -5.2% | +179.5% | -45.2% | -58.6% | |
| – | – | – | +15.0% | -32.0% | -175.7% | – | -5.6% | -67.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -1.6% | +4.6% | +589.4% | -94.3% | +499.3% | +483.3% | +5.3% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.